169 related articles for article (PubMed ID: 37028263)
1. Vitamin K antagonists but not non-vitamin K antagonists in addition on antiplatelet therapy should be associated with increase of hematoma volume and mortality in patients with intracerebral hemorrhage: A sub-analysis of PASTA registry study.
Nomura K; Suda S; Abe A; Iguchi Y; Yagita Y; Kanzawa T; Okubo S; Fujimoto S; Kimura K;
J Neurol Sci; 2023 May; 448():120643. PubMed ID: 37028263
[TBL] [Abstract][Full Text] [Related]
2. Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality.
Inohara T; Xian Y; Liang L; Matsouaka RA; Saver JL; Smith EE; Schwamm LH; Reeves MJ; Hernandez AF; Bhatt DL; Peterson ED; Fonarow GC
JAMA; 2018 Feb; 319(5):463-473. PubMed ID: 29372247
[TBL] [Abstract][Full Text] [Related]
3. Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD-AF and ORBIT-AF registries.
Lim TW; Camm AJ; Virdone S; Singer DE; Bassand JP; Fonarow GC; Fox KAA; Ezekowitz M; Gersh BJ; Kayani G; Hylek EM; Kakkar AK; Mahaffey KW; Pieper KS; Peterson ED; Piccini JP;
Clin Cardiol; 2023 Nov; 46(11):1398-1407. PubMed ID: 37596725
[TBL] [Abstract][Full Text] [Related]
4. Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage.
Gerner ST; Kuramatsu JB; Sembill JA; Sprügel MI; Hagen M; Knappe RU; Endres M; Haeusler KG; Sobesky J; Schurig J; Zweynert S; Bauer M; Vajkoczy P; Ringleb PA; Purrucker JC; Rizos T; Volkmann J; Müllges W; Kraft P; Schubert AL; Erbguth F; Nueckel M; Schellinger PD; Glahn J; Knappe UJ; Fink GR; Dohmen C; Stetefeld H; Fisse AL; Minnerup J; Hagemann G; Rakers F; Reichmann H; Schneider H; Rahmig J; Ludolph AC; Stösser S; Neugebauer H; Röther J; Michels P; Schwarz M; Reimann G; Bäzner H; Schwert H; Claßen J; Michalski D; Grau A; Palm F; Urbanek C; Wöhrle JC; Alshammari F; Horn M; Bahner D; Witte OW; Günther A; Hamann GF; Engelhorn T; Lücking H; Dörfler A; Schwab S; Huttner HB
Stroke; 2019 Jun; 50(6):1392-1402. PubMed ID: 31092170
[TBL] [Abstract][Full Text] [Related]
5. Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis.
Boulouis G; Morotti A; Pasi M; Goldstein JN; Gurol ME; Charidimou A
J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):263-270. PubMed ID: 29030422
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of Ischemic Versus Hemorrhagic Stroke in Patients Receiving Oral Anticoagulants: Results of the PASTA Study.
Suda S; Abe A; Iguchi Y; Yagita Y; Kanzawa T; Okubo S; Ohara N; Mizunari T; Yamazaki M; Nakajima N; Kondo K; Fujimoto S; Inoue T; Iwanaga T; Terasawa Y; Shibazaki K; Kono Y; Nakajima M; Nakajima M; Mishina M; Adachi K; Imafuku I; Nomura K; Nagao T; Yaguchi H; Okamoto S; Osaki M; Kimura K
Intern Med; 2022 Mar; 61(6):801-810. PubMed ID: 34483213
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes and Neuroimaging Profiles in Nondisabled Patients With Anticoagulant-Related Intracerebral Hemorrhage.
Lioutas VA; Goyal N; Katsanos AH; Krogias C; Zand R; Sharma VK; Varelas P; Malhotra K; Paciaroni M; Sharaf A; Chang J; Karapanayiotides T; Kargiotis O; Pappa A; Mai J; Pandhi A; Schroeder C; Tsantes A; Mehta C; Kerro A; Khan A; Mitsias PD; Selim MH; Alexandrov AV; Tsivgoulis G
Stroke; 2018 Oct; 49(10):2309-2316. PubMed ID: 30355114
[TBL] [Abstract][Full Text] [Related]
8. Outcome of intracerebral hemorrhage associated with different oral anticoagulants.
Wilson D; Seiffge DJ; Traenka C; Basir G; Purrucker JC; Rizos T; Sobowale OA; Sallinen H; Yeh SJ; Wu TY; Ferrigno M; Houben R; Schreuder FHBM; Perry LA; Tanaka J; Boulanger M; Al-Shahi Salman R; Jäger HR; Ambler G; Shakeshaft C; Yakushiji Y; Choi PMC; Staals J; Cordonnier C; Jeng JS; Veltkamp R; Dowlatshahi D; Engelter ST; Parry-Jones AR; Meretoja A; Werring DJ;
Neurology; 2017 May; 88(18):1693-1700. PubMed ID: 28381513
[TBL] [Abstract][Full Text] [Related]
9. Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome.
Seiffge DJ; Hooff RJ; Nolte CH; Béjot Y; Turc G; Ikenberg B; Berge E; Persike M; Dequatre-Ponchelle N; Strbian D; Pfeilschifter W; Zini A; Tveiten A; Næss H; Michel P; Sztajzel R; Luft A; Gensicke H; Traenka C; Hert L; Scheitz JF; De Marchis GM; Bonati LH; Peters N; Charidimou A; Werring DJ; Palm F; Reinhard M; Niesen WD; Nagao T; Pezzini A; Caso V; Nederkoorn PJ; Kägi G; von Hessling A; Padjen V; Cordonnier C; Erdur H; Lyrer PA; Brouns R; Steiner T; Tatlisumak T; Engelter ST;
Circulation; 2015 Sep; 132(13):1261-9. PubMed ID: 26232277
[TBL] [Abstract][Full Text] [Related]
10. Fatal oral anticoagulant-related intracranial hemorrhage: a systematic review and meta-analysis.
Katsanos AH; Schellinger PD; Köhrmann M; Filippatou A; Gurol ME; Caso V; Paciaroni M; Perren F; Alexandrov AV; Tsivgoulis G
Eur J Neurol; 2018 Oct; 25(10):1299-1302. PubMed ID: 29953696
[TBL] [Abstract][Full Text] [Related]
11. Fatal intracranial haemorrhage occurring after oral anticoagulant treatment initiation for secondary stroke prevention in patients with atrial fibrillation.
Tsivgoulis G; Katsanos AH; Seiffge DJ; Paciaroni M; Wilson D; Koga M; Macha K; Cappellari M; Kallmünzer B; Polymeris AA; Toyoda K; Caso V; Werring DJ; Engelter ST; De Marchis GM;
Eur J Neurol; 2020 Aug; 27(8):1612-1617. PubMed ID: 32333493
[TBL] [Abstract][Full Text] [Related]
12. Neuroimaging and clinical outcomes of oral anticoagulant-associated intracerebral hemorrhage.
Tsivgoulis G; Wilson D; Katsanos AH; Sargento-Freitas J; Marques-Matos C; Azevedo E; Adachi T; von der Brelie C; Aizawa Y; Abe H; Tomita H; Okumura K; Hagii J; Seiffge DJ; Lioutas VA; Traenka C; Varelas P; Basir G; Krogias C; Purrucker JC; Sharma VK; Rizos T; Mikulik R; Sobowale OA; Barlinn K; Sallinen H; Goyal N; Yeh SJ; Karapanayiotides T; Wu TY; Vadikolias K; Ferrigno M; Hadjigeorgiou G; Houben R; Giannopoulos S; Schreuder FHBM; Chang JJ; Perry LA; Mehdorn M; Marto JP; Pinho J; Tanaka J; Boulanger M; Al-Shahi Salman R; Jäger HR; Shakeshaft C; Yakushiji Y; Choi PMC; Staals J; Cordonnier C; Jeng JS; Veltkamp R; Dowlatshahi D; Engelter ST; Parry-Jones AR; Meretoja A; Mitsias PD; Alexandrov AV; Ambler G; Werring DJ
Ann Neurol; 2018 Nov; 84(5):694-704. PubMed ID: 30255970
[TBL] [Abstract][Full Text] [Related]
13. Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage.
Tsivgoulis G; Lioutas VA; Varelas P; Katsanos AH; Goyal N; Mikulik R; Barlinn K; Krogias C; Sharma VK; Vadikolias K; Dardiotis E; Karapanayiotides T; Pappa A; Zompola C; Triantafyllou S; Kargiotis O; Ioakeimidis M; Giannopoulos S; Kerro A; Tsantes A; Mehta C; Jones M; Schroeder C; Norton C; Bonakis A; Chang J; Alexandrov AW; Mitsias P; Alexandrov AV
Neurology; 2017 Sep; 89(11):1142-1151. PubMed ID: 28814457
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use.
Seiffge DJ; Goeldlin MB; Tatlisumak T; Lyrer P; Fischer U; Engelter ST; Werring DJ
J Neurol; 2019 Dec; 266(12):3126-3135. PubMed ID: 31541341
[TBL] [Abstract][Full Text] [Related]
15. Blood Pressure and Anticoagulation Reversal Management during Off-Hours in Oral Anticoagulation-Associated Intracerebral Hemorrhage.
Mrochen A; Sprügel MI; Gerner ST; Sembill JA; Lang S; Lücking H; Kuramatsu JB; Huttner HB
Cerebrovasc Dis; 2020; 49(2):177-184. PubMed ID: 32320990
[TBL] [Abstract][Full Text] [Related]
16. POST-NOAC: Portuguese observational study of intracranial hemorrhage on non-vitamin K antagonist oral anticoagulants.
Marques-Matos C; Alves JN; Marto JP; Ribeiro JA; Monteiro A; Araújo J; Silva F; Grenho F; Viana-Baptista M; Sargento-Freitas J; Pinho J; Azevedo E
Int J Stroke; 2017 Aug; 12(6):623-627. PubMed ID: 27903938
[TBL] [Abstract][Full Text] [Related]
17. Similar outcomes between vitamin K and non-vitamin K antagonist oral anticoagulants associated intracerebral hemorrhage.
Chen SJ; Yeh SJ; Tang SC; Lin SY; Tsai LK; Jeng JS
J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):106-112. PubMed ID: 30876786
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet Therapy in Primary Spontaneous and Oral Anticoagulation-Associated Intracerebral Hemorrhage.
Sprügel MI; Kuramatsu JB; Gerner ST; Sembill JA; Beuscher VD; Hagen M; Roeder SS; Lücking H; Struffert T; Dörfler A; Schwab S; Huttner HB
Stroke; 2018 Nov; 49(11):2621-2629. PubMed ID: 30355188
[TBL] [Abstract][Full Text] [Related]
19. Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
Park J; Jung JH; Choi EK; Lee SW; Kwon S; Lee SR; Kang J; Han KD; Park KW; Oh S; Lip GYH
PLoS One; 2022; 17(2):e0264538. PubMed ID: 35213632
[TBL] [Abstract][Full Text] [Related]
20. Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA Study.
Moreno-Arribas J; Bertomeu-González V; Anguita-Sanchez M; Cequier Á; Muñiz J; Castillo J; Sanchis J; Roldán I; Marín F; Bertomeu-Martínez V;
J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):150-6. PubMed ID: 26229096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
